K-numberK251664
Device nameSingle Use Aspiration Needle (NA-201SX-4021); Single Use Aspiration Needle (NA-201SX-4022)
ApplicantOlympus Medical Systems Corporation
Product codeKTI
Device classClass II
Decision dateJul 29, 2025
DecisionSubstantially Equivalent
Regulation874.4680
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Single Use Aspiration Needle NA-201SX-4021 and NA-201SX-4022 are sterile, single-use, disposable needles designed for ultrasound-guided fine needle aspiration (FNA) of submucosal and extramural lesions of the tracheobronchial tree. They are used in combination with ultrasound endoscopes to obtain tissue samples for diagnostic purposes.

Technological characteristics

The subject devices differ from the predicate (NA-U401SX-4025N) in needle gauge (21G/22G vs. 25G) and maximum insertion portion diameter (1.9mm/1.8mm vs. 1.5mm). They share identical indications for use, working length (700mm), needle length range (20-40mm), sterilization method (ethylene oxide), shelf life (3 years), mechanism of sampling (aspiration), materials (SUS304, NiTi, PTFE), and connector type (Luer lock). The subject devices are optimized for 2.2mm endoscope channels whereas the predicate supports 2.0-2.2mm channels.

Test standards cited

Biocompatibility testing was conducted in accordance with ISO 10993-1. Sterilization validation achieved a sterility assurance level of 10⁻⁶ using ethylene oxide.

Substantial equivalence argument

The subject devices are substantially equivalent because they share the same intended use (ultrasound-guided FNA of tracheobronchial lesions), same product code and regulatory classification (Class II, KTI), and nearly identical technological characteristics and operational features as the predicate device. Performance testing confirmed the subject devices meet or exceed acceptance criteria for insertion, piercing, visibility, aspiration, and structural integrity. Although the needle gauges and diameters differ, bench testing demonstrated that these changes do not introduce new safety or effectiveness risks, and biocompatibility testing showed no new biocompatibility concerns. The differences in needle specifications represent refinements optimized for current endoscope technology rather than fundamental design changes that would alter the device's safety or performance profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →